Sylvester Agbahiwe, PharmD, BCACP

Article

Impact of Liraglutide to Semaglutide Conversion on Glycemic Control and Cost Savings at a Veterans Affairs Medical Center

Author:: Sylvester Agbahiwe, PharmD, BCACP

Publish date: October 3, 2023

This study examined whether converting patients from liraglutide to semaglutide, both glucagon-line peptide 1 receptor agonists, would lead to chan...

Article

Burnt Out ? The Phenomenon of Type 2 Diabetes Mellitus in End-Stage Renal Disease

Author:: Sylvester Agbahiwe, PharmD, BCACP

Publish date: December 4, 2020

In patients with T2DM and ESRD, insulin is the antidiabetic medication of choice with a hemoglobin A1c target of 6 to 8%, using fructosamine levels...